fda warning letters compounded semaglutide 2025 september Drug compounders sue over declaration ending Wegovy shortage U.S. Food & Drug Administration

My notes were written out

Faster fat loss, better energy, fewer cravings, and stronger metabolic support than what weve seen from single or dual-pathway medications like Semaglutide (Ozempic) or Tirzepatide (Mounjaro)

we are protecting organs

And before licensing, manufacturers would have to prove that the drug was not only absorbed reliably and consistently via patch, and that these products worked as well as the (proven) injectable versions

Individual results depend on baseline kidney disease severity, diabetes control, and adherence to treatment

Notably, all the aforementioned mechanisms are intricately linked to SA